PEPAXTO
LIVE

Serial Number

79275014

Owner

Oncopeptides AB

Attorney

JOHN C. MCELWAINE

Filing Date

Nov 5, 2019

Add to watchlist:

No watchlists yet
View on USPTO

PEPAXTO Trademark

Serial Number: 79275014 • Registration: 6121369

PEPAXTO is a trademark filed by Oncopeptides AB on November 5, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Oncopeptides AB (10 trademarks)

Luntmakargatan 46

Entity Type: 09

Trademark Details

Filing Date

November 5, 2019

Registration Date

August 11, 2020

Published for Opposition

May 26, 2020

Goods & Services

Pharmaceutical, medicinal and veterinary preparations for the treatment of cancer, neoplastic diseases and multiple myeloma

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 11, 2025 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 4, 2023 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 26, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 3, 2020 FICS
FINAL DISPOSITION PROCESSED
Dec 3, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 11, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 11, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 6, 2020 NONP
ASSIGNED TO LIE
Apr 17, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 8, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 7, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 6, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 6, 2020 TROA
REFUSAL PROCESSED BY IB
Mar 27, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 7, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 7, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 15, 2020 RFCR
NON-FINAL ACTION WRITTEN
Feb 14, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 8, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 10, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 6, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 26, 2019 REPR